Avacopan in Anti-Neutrophil Cytoplasmic Autoantibodies-Associated Vasculitis in a Real-World Setting

Kidney Int Rep. 2024 Jul 6;9(9):2803-2808. doi: 10.1016/j.ekir.2024.07.007. eCollection 2024 Sep.

Jonas Zimmermann^{1

2}, Janis Sonnemann^{1

2}, Wolfram J Jabs³, Ulf Schönermarck⁴, Volker Vielhauer⁴, Markus Bieringer⁵, Udo Schneider⁶, Ralph Kettritz^{1

2}, Adrian Schreiber^{1

2}

¹ Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Germany.
² Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
³ Department of Nephrology, Vivantes Klinikum im Friedrichshain, Berlin, Germany.
⁴ Department of Medicine IV, Division of Nephrology, LMU University Hospital, LMU Munich, Germany.
⁵ Department of Cardiology and Nephrology, Helios Klinikum Berlin -Buch, Germany.
⁶ Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Germany.

No abstract available

Keywords: anti-neutrophil cytoplasmic autoantibodies (ANCA); avacopan; complement C5a; necrotizing crescentic glomerulonephritis; vasculitis.